ReviewGut microbes2026
Unveiling the impact of colonic pH and pH-sensing receptors in blood pressure regulation.
Review in Gut microbes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Tailored Drug Release with Improved Solubility via Spray Drying and Functional Ready-to-Fill Capsules.Pharmaceutics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Colonic luminal pH is a fundamental feature of the gut environment, shaped largely by the composition and activity of the gut microbiota. Diets rich in fermentable fiber lower the colonic pH primarily through their microbial fermentation, which produces short-chain fatty acids (SCFAs) as metabolic by-products. While the local effects of colonic pH on microbiota composition and intestinal function are increasingly well defined, its systemic consequences remain poorly understood. This review explores the determinants of colonic pH and its dynamic interactions with the gut microbiota, with a particular focus on how these processes may influence and be influenced by host physiology beyond the gastrointestinal (GI) tract. Since dietary fiber and its acidic metabolites confer protection against hypertension, there is growing interest in whether fiber-induced colonic acidification contributes to blood pressure regulation. Notably, participants with hypertension exhibit a higher (more alkaline) colonic minimum pH compared to those with normal blood pressure, further supporting the potential link between luminal acidity and blood pressure control. Particular attention has been given to proton-sensing G protein-coupled receptors (GPCRs), namely, GPR4, GPR65 and GPR68, which are increasingly implicated in regulating immune and cardiovascular functions. Emerging evidence suggests that gene-environment interactions involving GPR65 and GPR68 may influence blood pressure regulation through pH-sensitive pathways; GPR65 primarily via immune modulation, and GPR68 through vascular mechanisms. Therefore, understanding how colonic pH impacts these pathways may uncover novel therapeutic targets for hypertension.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.